Deficiency of C3a receptor attenuates the development of diabetic nephropathy
Objective Diabetic nephropathy (DN) is the leading cause of chronic kidney disease and end-stage renal disease. Emerging evidence suggests that complement activation is involved in the pathogenesis of DN. The aim of this study was to investigate the pathogenic role of C3a and C3a receptor (C3aR) in...
        Saved in:
      
    
          | Main Authors: | Ming-hui Zhao, Xiao-Qian Li, Dong-Yuan Chang | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | BMJ Publishing Group
    
        2019-05-01 | 
| Series: | BMJ Open Diabetes Research & Care | 
| Online Access: | https://drc.bmj.com/content/7/1/e000817.full | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
Similar Items
- 
                
                    Peroxisome Proliferator-Activated Receptors in Diabetic Nephropathy        
                          
 by: Shinji Kume, et al.
 Published: (2008-01-01)
- 
                
                    Predictive value of serum IgG/C3 levels for membranous nephropathy in diabetics with proteinuria and negative phospholipase A2 receptor antibody        
                          
 by: Huan Wang, et al.
 Published: (2024-12-01)
- 
                
                    Astragaloside IV attenuates podocyte apoptosis via regulating TXNIP/NLRP3/GSDMD signaling pathway in diabetic nephropathy        
                          
 by: Zhibo Hu, et al.
 Published: (2024-12-01)
- 
                
                    Toll-Like Receptors and Diabetic Nephropathy: A Review of Recent Advances        
                          
 by: Mohammad Sadra Gholami Chahkand, et al.
 Published: (2024-08-01)
- 
                
                    Study of Association of Vitamin D Receptor Gene Polymorphisms with Diabetic Nephropathy        
                          
 by: Bhuiya Esha, et al.
 Published: (2024-04-01)
 
       